The VU Journal Publishing Guide shows you the most important scientific journals in your field, with their impact metrics, Open Access possibilities and APC ...JAMA Dermatology. Audio (19:02) A Skin-Directed Scoring System for Epidermal Necrolysis. 1x. 0:00 / 0:00. Subscribe to Podcast. Full Text. Key Points. Question Is there a need for an EN skin-directed scoring system, consistent EN terminology, a better understanding of orphologic progression, and/or identification of the most-affected sites? ...The gut contains approximately 100 trillion commensal microorganisms, including viruses, archaea, bacteria, and unicellular eukaryotes that influence the development and function of the human neurological, immunological, and digestive systems from birth through adulthood. 1 These collective microbes and their genes comprise the gut microbiome, which has …Introduction Acne often persists into adulthood in women. However, few studies have specifically explored the lived experience of acne in adult populations. Objective To examine the lived experience of acne and its treatment among a cohort of adult women.. Design, Setting, and Participants A qualitative analysis was conducted from free listing and open …JAMA Dermatology Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 2168-6068.Chronic pruritus is a debilitating symptom that is associated with numerous dermatologic, neurologic, and systemic diseases. It is often resistant to treatment and can cause a severe reduction in quality of life. 1 Currently, to our knowledge, there is a lack of US Food and Drug Administration–approved therapies for pruritus, so treatment can be difficult and relies on …12 Jan 2022 ... Semenov, MD, MA, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, 40 Blossom St, Bartlett Hall 6R, Room 626, ...Physical examination results show multiple dome-shaped, skin-colored, firm papules arranged in a blaschkoid distribution. Telangiectasis could be seen on some ...Spironolactone is an androgen receptor antagonist that is an effective treatment for hormonally mediated acne. 1-4 Although generally well tolerated, spironolactone use is associated with hyperkalemia among patients with heart failure taking additional drugs that interfere with potassium excretion. 5 However, the prevalence of spironolactone-induced …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) The most common dermatologic treatment during a flare episode was topical corticosteroids (35% of flare episodes [178 of 513]) followed by other oral dermatologic treatments (eg, methotrexate, cyclosporine, tacrolimus; 13% [67 of 513]), and oral corticosteroids (11% [54 of 513]) . Opioids were prescribed during 21% of flare episodes (106 of 513). JAMA Dermatology. Key Points. Question What is the efficacy and safety of targeted interleukin-13 treatment with tralokinumab monotherapy in adolescents with moderate to severe atopic dermatitis? Findings In this randomized clinical trial of 289 patients aged 12 to 17 years, a statistically significant higher number of patients treated with tralokinumab vs …Feb 14, 2024 · Systemic Immunomodulatory Treatments for Atopic Dermatitis. Explore the latest treatments for vitiligo, hidradenitis suppurativa, lichen sclerosus, melanoma, cosmetic dermatology, and more. Formerly Archives of Dermatology. Explore the latest in dermatology, including diagnosis and management of allergic, inflammatory, autoimmune and genetic diseases of the skin.Read the January 1, 2024 issue. Volume 160, Number 1.COVID-19 and the Dermatology Workforce and Education. COVID-19 has changed the workforce and the way dermatologists practice and learn. Reassignment of …In individual patients, the risks and benefits of WW and treatment can be weighed using this algorithm. The frequency of follow-up visits (eg, every 3-6 months) should be based on the feasibility for individual cases and can be adjusted (preferably by visiting a dermatology outpatient clinic when feasible; if not possible, eg, follow-up through teledermatology or general practitioner) when ... Dr Micheletti is Images in Dermatology Editor for JAMA Dermatology. Dr Rosenbach is an Editorial Board member of JAMA Dermatology. Dr Shields is an Assistant Section Editor of JAMA Dermatology. Dr Shinkai is Chief Editor of JAMA Dermatology. Dr Mostaghimi is an Associate Editor of JAMA Dermatology. They were not involved in any of the decisions ... JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology. Key Points. Question What are the long-term clearance rates of treatments used in patients with actinic keratosis? Findings This systematic review and network meta-analysis included data from 15 randomized clinical trials reporting sustained clearance rates after at least 12 months of treatment as a proxy for long-term efficacy. …Introduction Acne often persists into adulthood in women. However, few studies have specifically explored the lived experience of acne in adult populations. Objective To examine the lived experience of acne and its treatment among a cohort of adult women.. Design, Setting, and Participants A qualitative analysis was conducted from free listing and open …JAMA Dermatology. Key Points. Question Is dietary behavior associated with acne in adults? Findings In this cross-sectional study of 24 452 participants in the French NutriNet-Santé study, the consumption of fatty and sugary products, sugary beverages, and milk was associated with current acne in adults. This association was noted after …Explore health information written for patients from JAMA Dermatology’s editors, including easy-to-understand explanations of atopic dermatitis, psoriasis, and more. Add to My …JAMA Network is a consortium of peer-reviewed medical publications that includes JAMA® and the JAMA Network journals. JAMA Dermatology does not hold itself responsible for statements made by any contributor. All articles published, including opinion articles, represent the views of the authors and do not reflect the policy of the Journal, the ... Read the January 1, 2024 issue. Volume 160, Number 1. The most common dermatologic treatment during a flare episode was topical corticosteroids (35% of flare episodes [178 of 513]) followed by other oral dermatologic treatments (eg, methotrexate, cyclosporine, tacrolimus; 13% [67 of 513]), and oral corticosteroids (11% [54 of 513]) . Opioids were prescribed during 21% of flare episodes (106 of 513). Importance Cutaneous squamous cell carcinoma (cSCC) has metastatic potential, but the prognostic value of current staging systems in nonselected patients is uncertain.. Objective To assess the effect of risk factors for metastasis and to evaluate validity and usefulness of 4 staging systems for cSCC using population-based data.. Design, Setting, and …Clean beauty, also known as natural skin care, is having a moment. From 2017 to 2018, the natural skin care market grew by 23% to 1.6 billion dollars, accounting for over 25% of the 5.6 billion dollars of annual skin care sales in 2018.1 Staunch warnings from influencers such as Gwyneth Paltrow,...Also known as pernio-likepseudo-chilblain, acute acro-ischemia, and “COVID toes,” the pattern of acral lesions is described as erythematous to purple purpuric macules, papules, and/or vesicles. Its close temporal appearance with the COVID-19 pandemic suggests that the two are associated. Galván Casas et al confirmed that 29 of 71 cases of ...Oct 2, 2019 · Key Points. Question What is the efficacy and safety of abrocitinib monotherapy in patients with moderate-to-severe atopic dermatitis?. Findings In this randomized clinical trial of 391 patients 12 years or older with moderate-to-severe atopic dermatitis, significantly greater proportions of patients treated with abrocitinib (200 mg or 100 mg) compared with placebo achieved an Investigator ... This phase 2b, placebo-controlled, randomized clinical trial evaluates the efficacy and safety of lebrikizumab, a novel, high-affinity, monoclonal antibody targeting interleukin (IL)–13 that selectively prevents formation of the IL-13Rα1/IL-4Rα heterodimer receptor signaling complex, in adults with... Psoriasis is a chronic skin condition caused by skin cells that multiply faster than normal due to a dysregulated immune system. Plaque psoriasis is the most common type of psoriasis, representing approximately 80% to 90% of cases. Typical plaque psoriasis appears as red, raised areas of skin (plaques), often covered with a characteristic ...Key Points. Question What is the risk of developing inflammatory bowel disease in children and adults with atopic dermatitis (AD)?. Finding This population-based cohort study of …It’s not just about fertility. The age at which you become parents could affect your kids’ mental health. It’s not just about fertility. The age at which you become parents could a...Feb 14, 2024 · Systemic Immunomodulatory Treatments for Atopic Dermatitis. Explore the latest treatments for vitiligo, hidradenitis suppurativa, lichen sclerosus, melanoma, …Key Points. Question What are the fertility rates and birth outcomes in female patients with psoriasis when compared with age- and practice-matched patients without psoriasis?. Findings This cohort study included 63 681 patients with psoriasis and 318 405 matched comparators of common reproductive ages from the UK Clinical Practice Research …JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Association of Risk of Incident Venous Thromboembolism With Atopic Dermatitis and Treatment With Janus Kinase Inhibitors: A Systematic Review and Meta-analysis | Venous Thromboembolism | JAMA …Wollenberg A , Barbarot S , Bieber T , et al; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and ... Aug 1, 2020 · Confirmation of the association between diet and acne is sought out by many, and with conflicting studies, it becomes murky. Several confounding factors have been controlled for and it appears the participants go through somewhat extensive questionnaires, with the number of uncompensated steps required in participation in this study, what is the impact, if any, of self-selection bias on the study. Necrobiotic xanthogranuloma (NXG) is a rare systemic disease first described by Kossard and Winkelmann 1 in 1980, and about 100 cases have been reported since then. 2-5 It is clinically characterized by indurated yellowish to red-orange or brown papules or nodules that grow into larger and in some cases very extensive plaques covering the face …JAMA Dermatology. Key Points. Question What are the long-term clearance rates of treatments used in patients with actinic keratosis? Findings This systematic review and network meta-analysis included data from 15 randomized clinical trials reporting sustained clearance rates after at least 12 months of treatment as a proxy for long-term efficacy. …JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your …JAMA Dermatology. Key Points. Question Do dupilumab regimens less frequent than once weekly or every 2 weeks maintain long-term efficacy and safety? Findings In this randomized clinical trial of 422 patients, high-responding patients previously treated for 16 weeks with 300 mg of dupilumab weekly or every 2 weeks who continued those …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …Explore health information written for patients from JAMA Dermatology’s editors, including easy-to-understand explanations of atopic dermatitis, psoriasis, and more. Add to My …Importance: Determining psoriasis prevalence is fundamental to understanding the burden of the disease, the populations most affected, and health policies to address the disease. Objective: (1) To determine the prevalence of psoriasis among adults in the US and (2) to evaluate the change in psoriasis prevalence over time since the 2003-2004 …Key Points. Question What are the patient characteristics and the disease course in adults with generalized pustular psoriasis in the United States?. Findings In this retrospective case series of 95 adults with generalized pustular psoriasis, 70.5% of patients were women with a mean age of 50.3 years. On initial presentation, more than one-third of patients were …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology …JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …This phase 2b, placebo-controlled, randomized clinical trial evaluates the efficacy and safety of lebrikizumab, a novel, high-affinity, monoclonal antibody targeting interleukin (IL)–13 that selectively prevents formation of the IL-13Rα1/IL-4Rα heterodimer receptor signaling complex, in adults with... The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your …JAMA Dermatology. Research. October 18, 2023. This systematic review and meta-analysis analyzes the risk of acne associated with Janus kinase (JAK) inhibitors across published phase 2 and 3 placebo-controlled randomized clinical trials of JAK inhibitors.JAMA Dermatology welcomed Mya Roberson, MSPH, PhD, Vanderbilt University, as the inaugural Associate Editor of Diversity, Inclusion, and Equity to lead further development of journal initiatives in partnership with this network team. 15 The journal’s Editorial Fellowship pilot program 16 will launch in the summer of 2023, with a call for applications in the late …Resident's Page · 1. Montgomery H, Winkelmann RK: Smooth-muscle tumors of the skin . · 2. Fisher WC, Helwig EB: Leiomyomas of the skin . · 3. Kloepfer HW,&...JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. JAMA Dermatology. Home New Online Current Issue For Authors. Podcast. Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA …The JAMA Dermatology Patient Page is a public service of JAMA Dermatology. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA Dermatology suggests that you consult your …JAMA Dermatology. Key Points. Question What are the safety, efficacy, and biomarker responses of dupilumab treatment in patients with erythrodermic atopic dermatitis (AD)? Findings In this post hoc analysis of 209 patients with erythrodermic AD in 6 randomized, placebo-controlled clinical trials, dupilumab treatment (either as …20 May 2016 ... Review in JAMA Dermatology journal See cases that were sent in https://t.co/LQTW8t8iTS…/ https://t.co/iTNrlbuzm3.Clean beauty, also known as natural skin care, is having a moment. From 2017 to 2018, the natural skin care market grew by 23% to 1.6 billion dollars, accounting for over 25% of the 5.6 billion dollars of annual skin care sales in 2018.1 Staunch warnings from influencers such as Gwyneth Paltrow,... Jan 7, 2013 · JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Kanade Shinkai, MD, PhD, Department of Dermatology, University of Calfornia, San Francisco, 1701 Divisadero St, San Francisco, CA 94115 ( [email protected]. In this Viewpoint, JAMA Dermatology editors review the skin findings seen in association with coronavirus disease 2019 (COVID-19), how best to respond to those. JAMA Dermatology. Key Points. Question Do dupilumab regimens less frequent than once weekly or every 2 weeks maintain long-term efficacy and safety? Findings In this randomized clinical trial of 422 patients, high-responding patients previously treated for 16 weeks with 300 mg of dupilumab weekly or every 2 weeks who continued those …Corresponding Author: Ruth Ann Vleugels, MD, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115 ([email protected]). Author Contributions: Dr Vleugels had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of …Aug 1, 2022 · Design, Setting, and ParticipantsThis was a multicenter, vehicle-controlled, double-blind, phase 3 randomized clinical trial (B-SIMPLE4) conducted in 55 clinics (mostly dermatology and pediatric) in the US from September 1, 2020, to July 21, 2021. JAMA Dermatology. Key Points. Question What is the association of secukinumab with active tuberculosis (TB) development, TB reactivation, and latent tuberculosis infection (LTBI) activation? Findings In this pooled cohort study of 12 319 patients with psoriasis, psoriatic arthritis, or ankylosing spondylitis, spontaneous reporting of new LTBI while …To explore the degree of stigma toward individuals with acne and whether these attitudes vary based on characteristics of the individuals with acne or of the survey participants. Design, Setting, and ParticipantsIn this cross-sectional internet survey study, 4 stock portraits of adults that varied in sex (male/female) and skin tone (light/dark ...JAMA Dermatology’s mission is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, to enable dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care. The journal publishes a broad range of innovative studies and trials that shift research and ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) . Before dermatology evaluation, he was treated for presumed facial imClean beauty, also known as natural skin care, is having a mo JAMA Dermatol. 2022 Dec 1;158(12):1351. doi: 10.1001/jamadermatol.2021.4239.JAMA Dermatology Patient Page. Measles. Bharath Balu, PhD; Eliot N. Mostow, MD, MPH. JAMA Dermatology. Measles (rubeola) is an infection caused by a highly contagious virus primarily spread by respiratory droplets. How Common Is Measles and How Contagious Is It? Measles is currently rare in the US because highly effective vaccines … Clark et al 1 described the atypical, or 30 Aug 2023 ... JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology ... Key Points. Question Are nutritional supp...
Continue Reading